He joined the NIH in 1963, working in the Laboratory of Viral Immunology in the Division of Biologics Standards (DBS). Dr. Parkman became Chief of the Section on General Virology in 1971.
Dr. Parkman went on to develop the first Rubella vaccine with Dr. Harry M. Meyer, Jr. at NIH; their vaccine started clinical trials in 1965 at the Arkansas Children’s Colony and was licensed commercially in 1969.
He was part of the team that received a patent in 1971 for the rubella immunity test. The Laboratory of Viral Immunology was, at the time, in Building 29A on the second floor.
Dive
class
grid-col-6
Span
class
caption
Dr. harry Harry M. Meyer, Jr., at left, and Dr. Paul D. Parkman, at right, with the rubella virus.